nodes	percent_of_prediction	percent_of_DWPC	metapath
Escitalopram—Orthostatic hypotension—Doxorubicin—muscle cancer	0.000793	0.000793	CcSEcCtD
Escitalopram—Abdominal pain upper—Doxorubicin—muscle cancer	0.000793	0.000793	CcSEcCtD
Escitalopram—Photosensitivity reaction—Methotrexate—muscle cancer	0.000791	0.000791	CcSEcCtD
Escitalopram—Hypokalaemia—Doxorubicin—muscle cancer	0.000791	0.000791	CcSEcCtD
Escitalopram—Breast disorder—Doxorubicin—muscle cancer	0.000785	0.000785	CcSEcCtD
Escitalopram—Anorexia—Etoposide—muscle cancer	0.000785	0.000785	CcSEcCtD
Escitalopram—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.000782	0.000782	CcSEcCtD
Escitalopram—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	0.000782	0.000782	CcSEcCtD
Escitalopram—Diarrhoea—Dactinomycin—muscle cancer	0.000778	0.000778	CcSEcCtD
Escitalopram—Pneumonia—Methotrexate—muscle cancer	0.000778	0.000778	CcSEcCtD
Escitalopram—Nasopharyngitis—Doxorubicin—muscle cancer	0.000777	0.000777	CcSEcCtD
Escitalopram—Infestation—Methotrexate—muscle cancer	0.000773	0.000773	CcSEcCtD
Escitalopram—Infestation NOS—Methotrexate—muscle cancer	0.000773	0.000773	CcSEcCtD
Escitalopram—Depression—Methotrexate—muscle cancer	0.000771	0.000771	CcSEcCtD
Escitalopram—Hypotension—Etoposide—muscle cancer	0.000769	0.000769	CcSEcCtD
Escitalopram—Gastritis—Doxorubicin—muscle cancer	0.000769	0.000769	CcSEcCtD
Escitalopram—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.000767	0.000767	CcSEcCtD
Escitalopram—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.000766	0.000766	CcSEcCtD
Escitalopram—Muscular weakness—Doxorubicin—muscle cancer	0.000766	0.000766	CcSEcCtD
Escitalopram—Abdominal distension—Doxorubicin—muscle cancer	0.000756	0.000756	CcSEcCtD
Escitalopram—Stomatitis—Methotrexate—muscle cancer	0.000754	0.000754	CcSEcCtD
Escitalopram—Conjunctivitis—Methotrexate—muscle cancer	0.000752	0.000752	CcSEcCtD
Escitalopram—Influenza—Doxorubicin—muscle cancer	0.000751	0.000751	CcSEcCtD
Escitalopram—Asthma—Doxorubicin—muscle cancer	0.000751	0.000751	CcSEcCtD
Escitalopram—Dysphagia—Doxorubicin—muscle cancer	0.000751	0.000751	CcSEcCtD
Escitalopram—Hypersensitivity—Vincristine—muscle cancer	0.000749	0.000749	CcSEcCtD
Escitalopram—Eosinophilia—Doxorubicin—muscle cancer	0.000743	0.000743	CcSEcCtD
Escitalopram—Sweating—Methotrexate—muscle cancer	0.000741	0.000741	CcSEcCtD
Escitalopram—Paraesthesia—Etoposide—muscle cancer	0.000739	0.000739	CcSEcCtD
Escitalopram—Haematuria—Methotrexate—muscle cancer	0.000737	0.000737	CcSEcCtD
Escitalopram—Pancreatitis—Doxorubicin—muscle cancer	0.000736	0.000736	CcSEcCtD
Escitalopram—Dyspnoea—Etoposide—muscle cancer	0.000734	0.000734	CcSEcCtD
Escitalopram—Somnolence—Etoposide—muscle cancer	0.000732	0.000732	CcSEcCtD
Escitalopram—Angina pectoris—Doxorubicin—muscle cancer	0.000731	0.000731	CcSEcCtD
Escitalopram—Hepatobiliary disease—Methotrexate—muscle cancer	0.000731	0.000731	CcSEcCtD
Escitalopram—Epistaxis—Methotrexate—muscle cancer	0.000729	0.000729	CcSEcCtD
Escitalopram—Asthenia—Vincristine—muscle cancer	0.000729	0.000729	CcSEcCtD
Escitalopram—Vomiting—Dactinomycin—muscle cancer	0.000723	0.000723	CcSEcCtD
Escitalopram—Bronchitis—Doxorubicin—muscle cancer	0.000722	0.000722	CcSEcCtD
Escitalopram—Agranulocytosis—Methotrexate—muscle cancer	0.000722	0.000722	CcSEcCtD
Escitalopram—Rash—Dactinomycin—muscle cancer	0.000717	0.000717	CcSEcCtD
Escitalopram—Decreased appetite—Etoposide—muscle cancer	0.000716	0.000716	CcSEcCtD
Escitalopram—Pancytopenia—Doxorubicin—muscle cancer	0.000713	0.000713	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Etoposide—muscle cancer	0.000711	0.000711	CcSEcCtD
Escitalopram—Fatigue—Etoposide—muscle cancer	0.00071	0.00071	CcSEcCtD
Escitalopram—Pain—Etoposide—muscle cancer	0.000704	0.000704	CcSEcCtD
Escitalopram—Constipation—Etoposide—muscle cancer	0.000704	0.000704	CcSEcCtD
Escitalopram—Dysuria—Doxorubicin—muscle cancer	0.000702	0.000702	CcSEcCtD
Escitalopram—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.000698	0.000698	CcSEcCtD
Escitalopram—Haemoglobin—Methotrexate—muscle cancer	0.000698	0.000698	CcSEcCtD
Escitalopram—Diarrhoea—Vincristine—muscle cancer	0.000695	0.000695	CcSEcCtD
Escitalopram—Haemorrhage—Methotrexate—muscle cancer	0.000694	0.000694	CcSEcCtD
Escitalopram—Hepatitis—Methotrexate—muscle cancer	0.000694	0.000694	CcSEcCtD
Escitalopram—Pollakiuria—Doxorubicin—muscle cancer	0.000694	0.000694	CcSEcCtD
Escitalopram—Pharyngitis—Methotrexate—muscle cancer	0.000689	0.000689	CcSEcCtD
Escitalopram—Urinary tract disorder—Methotrexate—muscle cancer	0.000685	0.000685	CcSEcCtD
Escitalopram—Photosensitivity reaction—Doxorubicin—muscle cancer	0.000685	0.000685	CcSEcCtD
Escitalopram—Weight increased—Doxorubicin—muscle cancer	0.000683	0.000683	CcSEcCtD
Escitalopram—Urethral disorder—Methotrexate—muscle cancer	0.00068	0.00068	CcSEcCtD
Escitalopram—Weight decreased—Doxorubicin—muscle cancer	0.000679	0.000679	CcSEcCtD
Escitalopram—Feeling abnormal—Etoposide—muscle cancer	0.000678	0.000678	CcSEcCtD
Escitalopram—Hyperglycaemia—Doxorubicin—muscle cancer	0.000677	0.000677	CcSEcCtD
Escitalopram—Nausea—Dactinomycin—muscle cancer	0.000676	0.000676	CcSEcCtD
Escitalopram—Pneumonia—Doxorubicin—muscle cancer	0.000673	0.000673	CcSEcCtD
Escitalopram—Gastrointestinal pain—Etoposide—muscle cancer	0.000673	0.000673	CcSEcCtD
Escitalopram—Dizziness—Vincristine—muscle cancer	0.000672	0.000672	CcSEcCtD
Escitalopram—Infestation NOS—Doxorubicin—muscle cancer	0.000669	0.000669	CcSEcCtD
Escitalopram—Infestation—Doxorubicin—muscle cancer	0.000669	0.000669	CcSEcCtD
Escitalopram—Visual impairment—Methotrexate—muscle cancer	0.000669	0.000669	CcSEcCtD
Escitalopram—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.000664	0.000664	CcSEcCtD
Escitalopram—Erythema multiforme—Methotrexate—muscle cancer	0.000656	0.000656	CcSEcCtD
Escitalopram—Neuropathy peripheral—Doxorubicin—muscle cancer	0.000656	0.000656	CcSEcCtD
Escitalopram—Urticaria—Etoposide—muscle cancer	0.000654	0.000654	CcSEcCtD
Escitalopram—Stomatitis—Doxorubicin—muscle cancer	0.000653	0.000653	CcSEcCtD
Escitalopram—Jaundice—Doxorubicin—muscle cancer	0.000653	0.000653	CcSEcCtD
Escitalopram—Body temperature increased—Etoposide—muscle cancer	0.000651	0.000651	CcSEcCtD
Escitalopram—Abdominal pain—Etoposide—muscle cancer	0.000651	0.000651	CcSEcCtD
Escitalopram—Urinary tract infection—Doxorubicin—muscle cancer	0.000651	0.000651	CcSEcCtD
Escitalopram—Conjunctivitis—Doxorubicin—muscle cancer	0.000651	0.000651	CcSEcCtD
Escitalopram—Eye disorder—Methotrexate—muscle cancer	0.000649	0.000649	CcSEcCtD
Escitalopram—Tinnitus—Methotrexate—muscle cancer	0.000647	0.000647	CcSEcCtD
Escitalopram—Vomiting—Vincristine—muscle cancer	0.000646	0.000646	CcSEcCtD
Escitalopram—Cardiac disorder—Methotrexate—muscle cancer	0.000644	0.000644	CcSEcCtD
Escitalopram—Sweating—Doxorubicin—muscle cancer	0.000642	0.000642	CcSEcCtD
Escitalopram—Rash—Vincristine—muscle cancer	0.000641	0.000641	CcSEcCtD
Escitalopram—Dermatitis—Vincristine—muscle cancer	0.00064	0.00064	CcSEcCtD
Escitalopram—Haematuria—Doxorubicin—muscle cancer	0.000638	0.000638	CcSEcCtD
Escitalopram—Headache—Vincristine—muscle cancer	0.000637	0.000637	CcSEcCtD
Escitalopram—Hepatobiliary disease—Doxorubicin—muscle cancer	0.000633	0.000633	CcSEcCtD
Escitalopram—Epistaxis—Doxorubicin—muscle cancer	0.000631	0.000631	CcSEcCtD
Escitalopram—Angiopathy—Methotrexate—muscle cancer	0.00063	0.00063	CcSEcCtD
Escitalopram—Sinusitis—Doxorubicin—muscle cancer	0.000628	0.000628	CcSEcCtD
Escitalopram—Immune system disorder—Methotrexate—muscle cancer	0.000627	0.000627	CcSEcCtD
Escitalopram—Mediastinal disorder—Methotrexate—muscle cancer	0.000626	0.000626	CcSEcCtD
Escitalopram—Agranulocytosis—Doxorubicin—muscle cancer	0.000625	0.000625	CcSEcCtD
Escitalopram—Chills—Methotrexate—muscle cancer	0.000623	0.000623	CcSEcCtD
Escitalopram—Alopecia—Methotrexate—muscle cancer	0.000613	0.000613	CcSEcCtD
Escitalopram—Bradycardia—Doxorubicin—muscle cancer	0.000612	0.000612	CcSEcCtD
Escitalopram—Mental disorder—Methotrexate—muscle cancer	0.000608	0.000608	CcSEcCtD
Escitalopram—Hypersensitivity—Etoposide—muscle cancer	0.000607	0.000607	CcSEcCtD
Escitalopram—Erythema—Methotrexate—muscle cancer	0.000604	0.000604	CcSEcCtD
Escitalopram—Malnutrition—Methotrexate—muscle cancer	0.000604	0.000604	CcSEcCtD
Escitalopram—Haemoglobin—Doxorubicin—muscle cancer	0.000604	0.000604	CcSEcCtD
Escitalopram—Nausea—Vincristine—muscle cancer	0.000604	0.000604	CcSEcCtD
Escitalopram—Rhinitis—Doxorubicin—muscle cancer	0.000603	0.000603	CcSEcCtD
Escitalopram—Hepatitis—Doxorubicin—muscle cancer	0.000601	0.000601	CcSEcCtD
Escitalopram—Haemorrhage—Doxorubicin—muscle cancer	0.000601	0.000601	CcSEcCtD
Escitalopram—Hypoaesthesia—Doxorubicin—muscle cancer	0.000598	0.000598	CcSEcCtD
Escitalopram—Pharyngitis—Doxorubicin—muscle cancer	0.000596	0.000596	CcSEcCtD
Escitalopram—Urinary tract disorder—Doxorubicin—muscle cancer	0.000594	0.000594	CcSEcCtD
Escitalopram—Oedema peripheral—Doxorubicin—muscle cancer	0.000592	0.000592	CcSEcCtD
Escitalopram—Dysgeusia—Methotrexate—muscle cancer	0.000592	0.000592	CcSEcCtD
Escitalopram—Asthenia—Etoposide—muscle cancer	0.000591	0.000591	CcSEcCtD
Escitalopram—Connective tissue disorder—Doxorubicin—muscle cancer	0.000591	0.000591	CcSEcCtD
Escitalopram—Urethral disorder—Doxorubicin—muscle cancer	0.000589	0.000589	CcSEcCtD
Escitalopram—Back pain—Methotrexate—muscle cancer	0.000584	0.000584	CcSEcCtD
Escitalopram—Pruritus—Etoposide—muscle cancer	0.000582	0.000582	CcSEcCtD
Escitalopram—Visual impairment—Doxorubicin—muscle cancer	0.000579	0.000579	CcSEcCtD
Escitalopram—Vision blurred—Methotrexate—muscle cancer	0.000569	0.000569	CcSEcCtD
Escitalopram—Erythema multiforme—Doxorubicin—muscle cancer	0.000568	0.000568	CcSEcCtD
Escitalopram—Diarrhoea—Etoposide—muscle cancer	0.000563	0.000563	CcSEcCtD
Escitalopram—Eye disorder—Doxorubicin—muscle cancer	0.000562	0.000562	CcSEcCtD
Escitalopram—Ill-defined disorder—Methotrexate—muscle cancer	0.000561	0.000561	CcSEcCtD
Escitalopram—Tinnitus—Doxorubicin—muscle cancer	0.00056	0.00056	CcSEcCtD
Escitalopram—Anaemia—Methotrexate—muscle cancer	0.000558	0.000558	CcSEcCtD
Escitalopram—Flushing—Doxorubicin—muscle cancer	0.000558	0.000558	CcSEcCtD
Escitalopram—Cardiac disorder—Doxorubicin—muscle cancer	0.000558	0.000558	CcSEcCtD
Escitalopram—Angiopathy—Doxorubicin—muscle cancer	0.000545	0.000545	CcSEcCtD
Escitalopram—Malaise—Methotrexate—muscle cancer	0.000545	0.000545	CcSEcCtD
Escitalopram—Dizziness—Etoposide—muscle cancer	0.000544	0.000544	CcSEcCtD
Escitalopram—Immune system disorder—Doxorubicin—muscle cancer	0.000543	0.000543	CcSEcCtD
Escitalopram—Vertigo—Methotrexate—muscle cancer	0.000543	0.000543	CcSEcCtD
Escitalopram—Mediastinal disorder—Doxorubicin—muscle cancer	0.000542	0.000542	CcSEcCtD
Escitalopram—Leukopenia—Methotrexate—muscle cancer	0.000541	0.000541	CcSEcCtD
Escitalopram—Chills—Doxorubicin—muscle cancer	0.000539	0.000539	CcSEcCtD
Escitalopram—Arrhythmia—Doxorubicin—muscle cancer	0.000537	0.000537	CcSEcCtD
Escitalopram—Alopecia—Doxorubicin—muscle cancer	0.000531	0.000531	CcSEcCtD
Escitalopram—Cough—Methotrexate—muscle cancer	0.000527	0.000527	CcSEcCtD
Escitalopram—Mental disorder—Doxorubicin—muscle cancer	0.000527	0.000527	CcSEcCtD
Escitalopram—Convulsion—Methotrexate—muscle cancer	0.000523	0.000523	CcSEcCtD
Escitalopram—Vomiting—Etoposide—muscle cancer	0.000523	0.000523	CcSEcCtD
Escitalopram—Malnutrition—Doxorubicin—muscle cancer	0.000523	0.000523	CcSEcCtD
Escitalopram—Erythema—Doxorubicin—muscle cancer	0.000523	0.000523	CcSEcCtD
Escitalopram—Rash—Etoposide—muscle cancer	0.000519	0.000519	CcSEcCtD
Escitalopram—Dermatitis—Etoposide—muscle cancer	0.000519	0.000519	CcSEcCtD
Escitalopram—Headache—Etoposide—muscle cancer	0.000516	0.000516	CcSEcCtD
Escitalopram—Flatulence—Doxorubicin—muscle cancer	0.000516	0.000516	CcSEcCtD
Escitalopram—Arthralgia—Methotrexate—muscle cancer	0.000514	0.000514	CcSEcCtD
Escitalopram—Myalgia—Methotrexate—muscle cancer	0.000514	0.000514	CcSEcCtD
Escitalopram—Chest pain—Methotrexate—muscle cancer	0.000514	0.000514	CcSEcCtD
Escitalopram—Tension—Doxorubicin—muscle cancer	0.000513	0.000513	CcSEcCtD
Escitalopram—Dysgeusia—Doxorubicin—muscle cancer	0.000512	0.000512	CcSEcCtD
Escitalopram—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000511	0.000511	CcSEcCtD
Escitalopram—Discomfort—Methotrexate—muscle cancer	0.000508	0.000508	CcSEcCtD
Escitalopram—Nervousness—Doxorubicin—muscle cancer	0.000508	0.000508	CcSEcCtD
Escitalopram—Back pain—Doxorubicin—muscle cancer	0.000506	0.000506	CcSEcCtD
Escitalopram—Muscle spasms—Doxorubicin—muscle cancer	0.000503	0.000503	CcSEcCtD
Escitalopram—Confusional state—Methotrexate—muscle cancer	0.000497	0.000497	CcSEcCtD
Escitalopram—Anaphylactic shock—Methotrexate—muscle cancer	0.000493	0.000493	CcSEcCtD
Escitalopram—Vision blurred—Doxorubicin—muscle cancer	0.000493	0.000493	CcSEcCtD
Escitalopram—Infection—Methotrexate—muscle cancer	0.00049	0.00049	CcSEcCtD
Escitalopram—Nausea—Etoposide—muscle cancer	0.000489	0.000489	CcSEcCtD
Escitalopram—Ill-defined disorder—Doxorubicin—muscle cancer	0.000485	0.000485	CcSEcCtD
Escitalopram—Nervous system disorder—Methotrexate—muscle cancer	0.000484	0.000484	CcSEcCtD
Escitalopram—Anaemia—Doxorubicin—muscle cancer	0.000484	0.000484	CcSEcCtD
Escitalopram—Thrombocytopenia—Methotrexate—muscle cancer	0.000483	0.000483	CcSEcCtD
Escitalopram—Agitation—Doxorubicin—muscle cancer	0.000481	0.000481	CcSEcCtD
Escitalopram—Skin disorder—Methotrexate—muscle cancer	0.000479	0.000479	CcSEcCtD
Escitalopram—Hyperhidrosis—Methotrexate—muscle cancer	0.000477	0.000477	CcSEcCtD
Escitalopram—Malaise—Doxorubicin—muscle cancer	0.000472	0.000472	CcSEcCtD
Escitalopram—Vertigo—Doxorubicin—muscle cancer	0.00047	0.00047	CcSEcCtD
Escitalopram—Anorexia—Methotrexate—muscle cancer	0.00047	0.00047	CcSEcCtD
Escitalopram—Syncope—Doxorubicin—muscle cancer	0.000469	0.000469	CcSEcCtD
Escitalopram—Leukopenia—Doxorubicin—muscle cancer	0.000468	0.000468	CcSEcCtD
Escitalopram—Palpitations—Doxorubicin—muscle cancer	0.000462	0.000462	CcSEcCtD
Escitalopram—Hypotension—Methotrexate—muscle cancer	0.000461	0.000461	CcSEcCtD
Escitalopram—Loss of consciousness—Doxorubicin—muscle cancer	0.00046	0.00046	CcSEcCtD
Escitalopram—Cough—Doxorubicin—muscle cancer	0.000457	0.000457	CcSEcCtD
Escitalopram—Convulsion—Doxorubicin—muscle cancer	0.000453	0.000453	CcSEcCtD
Escitalopram—Hypertension—Doxorubicin—muscle cancer	0.000452	0.000452	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000449	0.000449	CcSEcCtD
Escitalopram—Insomnia—Methotrexate—muscle cancer	0.000446	0.000446	CcSEcCtD
Escitalopram—Arthralgia—Doxorubicin—muscle cancer	0.000445	0.000445	CcSEcCtD
Escitalopram—Chest pain—Doxorubicin—muscle cancer	0.000445	0.000445	CcSEcCtD
Escitalopram—Myalgia—Doxorubicin—muscle cancer	0.000445	0.000445	CcSEcCtD
Escitalopram—Anxiety—Doxorubicin—muscle cancer	0.000444	0.000444	CcSEcCtD
Escitalopram—Paraesthesia—Methotrexate—muscle cancer	0.000443	0.000443	CcSEcCtD
Escitalopram—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000442	0.000442	CcSEcCtD
Escitalopram—Discomfort—Doxorubicin—muscle cancer	0.00044	0.00044	CcSEcCtD
Escitalopram—Dyspnoea—Methotrexate—muscle cancer	0.00044	0.00044	CcSEcCtD
Escitalopram—Somnolence—Methotrexate—muscle cancer	0.000438	0.000438	CcSEcCtD
Escitalopram—Dry mouth—Doxorubicin—muscle cancer	0.000436	0.000436	CcSEcCtD
Escitalopram—Dyspepsia—Methotrexate—muscle cancer	0.000434	0.000434	CcSEcCtD
Escitalopram—Confusional state—Doxorubicin—muscle cancer	0.000431	0.000431	CcSEcCtD
Escitalopram—Decreased appetite—Methotrexate—muscle cancer	0.000429	0.000429	CcSEcCtD
Escitalopram—Anaphylactic shock—Doxorubicin—muscle cancer	0.000427	0.000427	CcSEcCtD
Escitalopram—Oedema—Doxorubicin—muscle cancer	0.000427	0.000427	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000426	0.000426	CcSEcCtD
Escitalopram—Fatigue—Methotrexate—muscle cancer	0.000425	0.000425	CcSEcCtD
Escitalopram—Infection—Doxorubicin—muscle cancer	0.000424	0.000424	CcSEcCtD
Escitalopram—Pain—Methotrexate—muscle cancer	0.000422	0.000422	CcSEcCtD
Escitalopram—Shock—Doxorubicin—muscle cancer	0.00042	0.00042	CcSEcCtD
Escitalopram—Nervous system disorder—Doxorubicin—muscle cancer	0.000419	0.000419	CcSEcCtD
Escitalopram—Thrombocytopenia—Doxorubicin—muscle cancer	0.000418	0.000418	CcSEcCtD
Escitalopram—Tachycardia—Doxorubicin—muscle cancer	0.000417	0.000417	CcSEcCtD
Escitalopram—Skin disorder—Doxorubicin—muscle cancer	0.000415	0.000415	CcSEcCtD
Escitalopram—Hyperhidrosis—Doxorubicin—muscle cancer	0.000413	0.000413	CcSEcCtD
Escitalopram—Anorexia—Doxorubicin—muscle cancer	0.000407	0.000407	CcSEcCtD
Escitalopram—Feeling abnormal—Methotrexate—muscle cancer	0.000406	0.000406	CcSEcCtD
Escitalopram—Gastrointestinal pain—Methotrexate—muscle cancer	0.000403	0.000403	CcSEcCtD
Escitalopram—Hypotension—Doxorubicin—muscle cancer	0.000399	0.000399	CcSEcCtD
Escitalopram—Urticaria—Methotrexate—muscle cancer	0.000392	0.000392	CcSEcCtD
Escitalopram—Body temperature increased—Methotrexate—muscle cancer	0.00039	0.00039	CcSEcCtD
Escitalopram—Abdominal pain—Methotrexate—muscle cancer	0.00039	0.00039	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000389	0.000389	CcSEcCtD
Escitalopram—Insomnia—Doxorubicin—muscle cancer	0.000386	0.000386	CcSEcCtD
Escitalopram—Paraesthesia—Doxorubicin—muscle cancer	0.000383	0.000383	CcSEcCtD
Escitalopram—Dyspnoea—Doxorubicin—muscle cancer	0.000381	0.000381	CcSEcCtD
Escitalopram—Somnolence—Doxorubicin—muscle cancer	0.00038	0.00038	CcSEcCtD
Escitalopram—Dyspepsia—Doxorubicin—muscle cancer	0.000376	0.000376	CcSEcCtD
Escitalopram—Decreased appetite—Doxorubicin—muscle cancer	0.000371	0.000371	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000369	0.000369	CcSEcCtD
Escitalopram—Fatigue—Doxorubicin—muscle cancer	0.000368	0.000368	CcSEcCtD
Escitalopram—Pain—Doxorubicin—muscle cancer	0.000365	0.000365	CcSEcCtD
Escitalopram—Constipation—Doxorubicin—muscle cancer	0.000365	0.000365	CcSEcCtD
Escitalopram—Hypersensitivity—Methotrexate—muscle cancer	0.000363	0.000363	CcSEcCtD
Escitalopram—Asthenia—Methotrexate—muscle cancer	0.000354	0.000354	CcSEcCtD
Escitalopram—Feeling abnormal—Doxorubicin—muscle cancer	0.000352	0.000352	CcSEcCtD
Escitalopram—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000349	0.000349	CcSEcCtD
Escitalopram—Pruritus—Methotrexate—muscle cancer	0.000349	0.000349	CcSEcCtD
Escitalopram—Urticaria—Doxorubicin—muscle cancer	0.000339	0.000339	CcSEcCtD
Escitalopram—Body temperature increased—Doxorubicin—muscle cancer	0.000338	0.000338	CcSEcCtD
Escitalopram—Abdominal pain—Doxorubicin—muscle cancer	0.000338	0.000338	CcSEcCtD
Escitalopram—Diarrhoea—Methotrexate—muscle cancer	0.000337	0.000337	CcSEcCtD
Escitalopram—Dizziness—Methotrexate—muscle cancer	0.000326	0.000326	CcSEcCtD
Escitalopram—Hypersensitivity—Doxorubicin—muscle cancer	0.000315	0.000315	CcSEcCtD
Escitalopram—Vomiting—Methotrexate—muscle cancer	0.000314	0.000314	CcSEcCtD
Escitalopram—Rash—Methotrexate—muscle cancer	0.000311	0.000311	CcSEcCtD
Escitalopram—Dermatitis—Methotrexate—muscle cancer	0.000311	0.000311	CcSEcCtD
Escitalopram—Headache—Methotrexate—muscle cancer	0.000309	0.000309	CcSEcCtD
Escitalopram—Asthenia—Doxorubicin—muscle cancer	0.000306	0.000306	CcSEcCtD
Escitalopram—Pruritus—Doxorubicin—muscle cancer	0.000302	0.000302	CcSEcCtD
Escitalopram—Nausea—Methotrexate—muscle cancer	0.000293	0.000293	CcSEcCtD
Escitalopram—Diarrhoea—Doxorubicin—muscle cancer	0.000292	0.000292	CcSEcCtD
Escitalopram—Dizziness—Doxorubicin—muscle cancer	0.000282	0.000282	CcSEcCtD
Escitalopram—Vomiting—Doxorubicin—muscle cancer	0.000271	0.000271	CcSEcCtD
Escitalopram—Rash—Doxorubicin—muscle cancer	0.000269	0.000269	CcSEcCtD
Escitalopram—Dermatitis—Doxorubicin—muscle cancer	0.000269	0.000269	CcSEcCtD
Escitalopram—Headache—Doxorubicin—muscle cancer	0.000267	0.000267	CcSEcCtD
Escitalopram—Nausea—Doxorubicin—muscle cancer	0.000254	0.000254	CcSEcCtD
